Search research articles
Contact Us
Filters
Showing results (181-190 of 217) with videos related to
Page
of 22
Sort By:
Experimental Gerontology
|
May 25, 2024
Aging-dependent mitochondrial bioenergetic impairment in the skeletal muscle of NNT-deficient mice
Claudia D C Navarro, Annelise Francisco, Ericka F D Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
J H Park, S F Jonas, G Bataillon, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
February 21, 2013
Evaluation of four DNA extraction protocols for Brucella abortus detection by PCR in tissues from experimentally infected cows with the 2308 strain
M P Vejarano, M Matrone, L B Keid, et al.
British Journal of Cancer
|
April 1, 2004
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia
F Stessels, G Van den Eynden, I Van der Auwera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2020
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
P Schmid, R Salgado, Y H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2014
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, et al.
Oncotarget
|
September 22, 2021
High expression of Myosin 1g in pediatric acute lymphoblastic leukemia
Laura A Estrada-Abreo, Leonor Rodríguez-Cruz, Yanelly Garfias-Gómez, et al.
ESMO Open
|
June 12, 2026
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study
G Nader-Marta, L Ameye, D Martins-Branco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 28, 2018
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
S J Luen, R Salgado, M V Dieci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
G Pruneri, M Lazzeroni, V Bagnardi, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 217) with videos related to
Sort By:
Page
of 22
Experimental Gerontology
|
May 25, 2024
Aging-dependent mitochondrial bioenergetic impairment in the skeletal muscle of NNT-deficient mice
Claudia D C Navarro, Annelise Francisco, Ericka F D Costa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
J H Park, S F Jonas, G Bataillon, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
February 21, 2013
Evaluation of four DNA extraction protocols for Brucella abortus detection by PCR in tissues from experimentally infected cows with the 2308 strain
M P Vejarano, M Matrone, L B Keid, et al.
British Journal of Cancer
|
April 1, 2004
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia
F Stessels, G Van den Eynden, I Van der Auwera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2020
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
P Schmid, R Salgado, Y H Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2014
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S Loi, S Michiels, R Salgado, et al.
Oncotarget
|
September 22, 2021
High expression of Myosin 1g in pediatric acute lymphoblastic leukemia
Laura A Estrada-Abreo, Leonor Rodríguez-Cruz, Yanelly Garfias-Gómez, et al.
ESMO Open
|
June 12, 2026
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study
G Nader-Marta, L Ameye, D Martins-Branco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 28, 2018
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
S J Luen, R Salgado, M V Dieci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
G Pruneri, M Lazzeroni, V Bagnardi, et al.
Page
of 22